ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank88
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-1.47
↑ 69% vs avg
Percentile
P88
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-4.70
Historical baseline
PeriodValueYoY Change
2025-1.47+19.7%
2024-1.83+6.6%
2023-1.96+12.9%
2022-2.25-8.7%
2021-2.07+38.4%
2020-3.36-140.0%
2019-1.40+88.6%
2018-12.32+21.1%
2017-15.62-